Abstract:The aim of this review was to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and optic nerve diseases, describing the available cell sources and the challenges involved in such treatments when these techniques are applied in real clinical practice. Sources include human fetal retinal stem cells, allogenic cadaveric human cells, adult hippocampal neural stem cells, human CNS stem cells, ciliary pigmented epithelial cells, limbal stem cells, retinal progenitor cells (RPCs), human pluripotent stem cells (PSCs) (including both human embryonic stem cells (ESCs) and human induced pluripotent stem cells (iPSCs)) and mesenchymal stem cells (MSCs). Of these, RPCs, PSCs and MSCs have already entered early-stage clinical trials since they can all differentiate into RPE, photoreceptors or ganglion cells, and have demonstrated safety, while showing some indicators of efficacy. Stem/progenitor cell therapies for retinal diseases still have some drawbacks, such as the inhibition of proliferation and/or differentiation in vitro (with the exception of RPE) and the limited long-term survival and functioning of grafts in vivo. Some other issues remain to be solved concerning the clinical translation of cell-based therapy, including (1) the ability to enrich for specific retinal subtypes; (2) cell survival; (3) cell delivery, which may need to incorporate a scaffold to induce correct cell polarization, which increases the size of the retinotomy in surgery and, therefore, the chance of severe complications; (4) the need to induce a localized retinal detachment to perform the subretinal placement of the transplanted cell; (5) the evaluation of the risk of tumor formation caused by the undifferentiated stem cells and prolific progenitor cells. Despite these challenges, stem/progenitor cells represent the most promising strategy for retinal and optic nerve disease treatment in the near future, and therapeutics assisted by gene techniques, neuroprotective compounds and artificial devices can be applied to fulfil clinical needs.

Progress in stem cell transplantation for treatment of retinal ganglion cell damage diseases

[The Advances in Research on Precisely Inducing Retinal Ganglion Cells from Stem Cells].

Research Progress of Stem Cell-Derived RPE Cell Transplantation Therapy for Retinal Degenerative Diseases

Advances of Stem Cell Transplantation in the Treatment of Retinal Degeneration

Stem/progenitor Cell-Based Transplantation for Retinal Degeneration: a Review of Clinical Trials.

Towards Retinal Ganglion Cell Regeneration

Progress of stem cells applications in retina repair

Stemming retinal regeneration with pluripotent stem cells

Stem/progenitor cells and biodegradable scaffolds in the treatment of retinal degenerative diseases.

Research advances of stem cells applications in retinal repairment

Stem cell therapy and the retina

Stem cells and repair of injured retina

Progress of stem/progenitor cell-based therapy for retinal degeneration

Advances in Regeneration of Retinal Ganglion Cells and Optic Nerves

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Stem cells for investigation and treatment of inherited retinal disease

Progress in Photoreceptor Replacement Therapy for Retinal Degenerative Diseases

Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges

New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting

Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review

Recent research advanceces in neural retina remodeling in vitro and degenerative eye disease